POLD1 and myasthenia gravis: Moreover, cCa→A and cCt→T mutations, while enriched with MG treatments, are associated with other etiologies including defective mismatch repair, POLE and POLD mutations, and tobacco smoke [73–77], and can therefore confound further analysis.